|
Quotes & Info
|
| BIOS > SEC Filings for BIOS > Form 8-K on 20-Jan-2009 | All Recent SEC Filings |
20-Jan-2009
Change in Directors or Principal Officers
We entered into amendments to the severance agreements for Stanley G. Rosenbaum,
our Executive Vice President and Chief Financial Officer, and Barry A. Posner,
our Executive Vice President and General Counsel.
Each of the severance agreements was amended to provide that any payments,
benefits and vesting to which an executive may be entitled would be provided
without regard to the deductibility of such payments, benefits and vesting under
Section 280G of the Internal Revenue Code (the "Code") and without regard to
whether such payments would subject the executive to the federal excise tax
levied on certain "excess parachute payments" under Code Section 4999 (the
"Excise Tax"). If any portion of the payments, benefits and vesting to or for
the executive's benefit constitutes an "excess parachute payment" within the
meaning of Code Section 280G, we would pay to the executive an additional amount
that after reduction for all taxes (including the Excise Tax) with respect to
such gross-up payment equals the Excise Tax on such payment; provided, that to
the extent any gross-up payment would be considered deferred compensation for
purposes of Code Section 409A, the manner and time of payment and the affected
provisions of the severance agreement would be adjusted to the extent necessary
(but only to the extent necessary) to comply with the requirements of Code
Section 409A so that the payment does not give rise to the interest or
additional tax amounts to the executive as described at Code
Section 409A(a)(1)(B) or Code Section 409A(b)(4).
Each of the severance agreements was also amended to provide that it, to the
extent applicable, comply with Code Section 409A in accordance with the
provisions set forth the severance agreement, as amended.
The foregoing summary is qualified by reference to the complete full text of the
amendments which are attached to this Form 8-K as
Exhibits 10.1 and 10.2 and incorporated by reference.
Item 9.01 Financial Statements and Exhibits.
(c) Exhibits. The following are furnished as exhibits to this Current Report:
Exhibit No. Description of Exhibit
10.1 Form of Amendment to Severance Agreement between BioScrip, Inc. and
Stanley G. Rosenbaum
10.2 Form of Amendment to Severance Agreement between BioScrip, Inc. and Barry
A. Posner
|
|
|